CANCERS UPDATE.
Sponsor of Links. Here are some recent peer-reviewed studies (2023–2025) on breast cancer treatment advancements : 🧪 1. Third‐Generation Tubulin Inhibitors for Cancer Focus: New tubulin inhibitors (compounds 11a–11l) tested in breast cancer cells (MCF line). Takeaway: Promising new class of anti-cancer agents. Read More 🖥️ 2. Automated Software in Mammography Focus: Use of AI tools to assess mammographic image quality. Takeaway: Enhances accuracy and reduces diagnostic errors in early detection. Read More 🌍 3. Global Review on Advanced Breast Cancer (ABC) Focus: Barriers to treatment access worldwide for ABC. Takeaway: Calls for equitable, lifelong care systems. Read More 💊 4. CDK4/6 Inhibitor Journey – Palbociclib Focus: Review of palbociclib, the first CDK4/6 inhibitor, and future directions. Takeaway: CDK inhibitors remain a cornerstone for HR+/HER2− breast cancer. Read More 🤖 5. AI for Tumor-Infiltrating Lympho...
